Product Description
Select Omalirel 150mg Injection as a highlighted and monumental breakthrough for the management of severe asthma. This new release from Reliance Life Sciences stands as the crowning achievement in monoclonal antibody therapy, offering a kingly solution for both adults and adolescents. Formulated with omalizumab 150mg, it comes in a sterile, lyophilized powder packed in a 1x1 vial, specifically intended for subcutaneous administration. Prescription-only and strictly for hospital supply, Omalirel assures superior sterility, stability, and reliability with a shelf life of 24 months, setting a new standard for severe asthma care.
Features and Competitive Advantages of Omalirel 150mg Injection
Omalirel 150mg Injection offers a kingly advancement in severe asthma therapy, featuring a recombinant humanized monoclonal antibody backed by sterling sterility and refrigerated storage. Its monumental efficacy is trusted for hospital supply, with the advantage of targeted action in adults and adolescents. Marketed by Reliance Life Sciences, it stands highlighted among competitors due to its originator backing, consistent purity, and leading safety profile, granting reliable control to users and healthcare professionals alike.
Certifications, Sampling, and Packaging Details for Omalirel 150mg Injection
The monumental value of Omalirel 150mg Injection is verified through stringent certifications for sterility and quality assurance. Available with a highlighted, single-vial packaging, it ensures maximum safety and freshness, supporting a shelf life of 24 months under refrigerated storage. Samples may be available upon formal request. The asking price reflects its premium, kingly market value in India. Exporter, manufacturer, and supplier backing further distinguish this new release for hospitals and pharmacies seeking superior reliability and compliance.
FAQ's of Omalirel 150mg Injection:
Q: How should Omalirel 150mg Injection be stored to maintain its effectiveness?
A: Omalirel 150mg Injection must be refrigerated, stored between 2C to 8C, to preserve its stability and sterility throughout its 24-month shelf life.
Q: What is the recommended route and frequency of administration for Omalirel 150mg Injection?
A: This injection is intended for subcutaneous administration and is prescribed by a healthcare professional, based on individual patient requirements and clinical judgment.
Q: When is Omalirel 150mg Injection indicated for use?
A: Omalirel is indicated for the treatment of severe asthma in adults and adolescents, particularly when standard therapies fail to provide adequate control.
Q: Where is Omalirel 150mg Injection typically used and dispensed?
A: The injection is primarily supplied to hospitals for prescription use and is administered under medical supervision to ensure patient safety.
Q: What are the primary benefits of choosing Omalirel 150mg Injection for severe asthma?
A: Omalirel offers precise, targeted action through its recombinant humanized monoclonal antibody formulation, providing monumental improvement in asthma management with high safety and tolerability.
Q: How does Omalirel 150mg Injection stand out among similar products in the market?
A: Highlighted by its originator status with Reliance Life Sciences, kingly efficacy, and validated sterility, Omalirel excels in reliability and patient outcomes, setting it apart from generic alternatives.